Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
1993-1-8
|
pubmed:abstractText |
The significance of apoptosis in relation to the development and progression of prostate cancer remains largely undefined. bcl-2 is an oncogene that functions by overriding apoptosis. bcl-2 expression was localized to the basal epithelial cells in the normal human prostate with the use of immunohistochemistry. Androgen-dependent and androgen-independent prostate carcinomas were evaluated immunohistochemically for bcl-2 expression. bcl-2 was undetectable in 13 of 19 cases of androgen-dependent cancers. In contrast, androgen-independent cancers displayed diffuse, high levels of bcl-2 staining (P < 0.01). In rats, steady-state levels of bcl-2 mRNA, assessed by S1 assays, reached maximum levels 10 days following castration. Addition of exogenous testosterone with, or without, flutamide demonstrated that the increased bcl-2 mRNA resulted from androgen ablation. Our findings indicate that bcl-2 expression is augmented following androgen ablation and is correlated with the progression of prostate cancer from androgen dependence to androgen independence.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
52
|
pubmed:geneSymbol |
bcl-2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6940-4
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1458483-Androgens,
pubmed-meshheading:1458483-Animals,
pubmed-meshheading:1458483-Apoptosis,
pubmed-meshheading:1458483-Gene Expression,
pubmed-meshheading:1458483-Male,
pubmed-meshheading:1458483-Neoplasms, Hormone-Dependent,
pubmed-meshheading:1458483-Prostate,
pubmed-meshheading:1458483-Prostatic Neoplasms,
pubmed-meshheading:1458483-Proto-Oncogene Proteins,
pubmed-meshheading:1458483-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:1458483-Proto-Oncogenes,
pubmed-meshheading:1458483-Rats,
pubmed-meshheading:1458483-Rats, Sprague-Dawley
|
pubmed:year |
1992
|
pubmed:articleTitle |
Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
|
pubmed:affiliation |
Department of Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|